Company intelligence / Profile preview

Somna Therapeutics

Germantown, Wisconsin, USAprweb.com ↗

Ownership: Private
Employees: ~1
Development stage: Commercial

Overview

The company developed and commercialized the Reflux Band™ (formerly Reza Band), an FDA-cleared, non-pharmacologic wearable device for laryngopharyngeal and extraesophageal acid reflux. Clinical studies showed significant symptom improvement in up to 86% of users within two weeks. The product was available OTC in the US and select international markets before acquisition.

Therapeutic areas: Gastroenterology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

REZA BAND UES Assist Device

Commercial

Indications: Acid reflux disease

Partnerships

Medical College of Wisconsin [founding partnership]Restech [acquirer/partner post-acquisition]

Beyond the preview

Go deeper on Somna Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somna Therapeutics.

Explore the full profile